Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A primary, benign or malignant neoplasm of the uterine corpus characterized by the presence of an epithelial and a mesenchymal component. Representative examples include adenomyoma, adenosarcoma, and carcinosarcoma.
Biomarker and diagnostic research for uterine corpus mixed epithelial and mesenchymal neoplasm has been reported in the published literature.
No clinical trials have been registered for uterine corpus mixed epithelial and mesenchymal neoplasm.
6 publications have been identified in PubMed for uterine corpus mixed epithelial and mesenchymal neoplasm. Research spans Case Report / Case Series (67%) and Diagnostic / Biomarker (33%).
Jafari F (2026). [PMID: 41732783](https://pubmed.ncbi.nlm.nih.gov/41732783/). *Rare tumors*. [Case Report / Case Series]
Yu J (2026). [PMID: 41731783](https://pubmed.ncbi.nlm.nih.gov/41731783/). *Medicine*. [Diagnostic / Biomarker]
Kitamura K (2025). [PMID: 40842755](https://pubmed.ncbi.nlm.nih.gov/40842755/). *Cureus*. [Case Report / Case Series]
Lee S (2025). [PMID: 39792897](https://pubmed.ncbi.nlm.nih.gov/39792897/). *Human reproduction (Oxford, England)*. [Diagnostic / Biomarker]
Akhila TR (2025). [PMID: 40949704](https://pubmed.ncbi.nlm.nih.gov/40949704/). *Iranian journal of veterinary research*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:33 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center